Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05492422 · ClinicalTrials.gov registry record · NA

Central Executive Training and Parent Training for ADHD

A NA study of ADHD, sponsored by Florida State University.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05492422 is a NA study of ADHD that is actively recruiting participants, run by Florida State University. The registered enrollment target is 200 participants, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05492422, a NA study of ADHD, is actively recruiting participants, sponsored by Florida State University.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving children's working memory abilities. BPT is a therapeutic intervention that improves family functioning and child oppositional-defiant (ODD) symptoms by changing parenting behaviors. Their combined use is expected to provide complementary and additive benefits, particularly if CET is delivered before BPT.

Conditions Studied

Interventions

  • DEVICE Central Executive Training (CET)
  • BEHAVIORAL Behavioral Parent Training (BPT)

Study Locations (1)

Florida

  • Florida State University - Tallahassee

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2022-10-03
Est. Completion 2027-07-31
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT05492422

The ClinicalTrials.gov registry entry for NCT05492422 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 2 interventions - of which Central Executive Training (CET) is the first listed.

NCT05492422 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT05492422 about?

NCT05492422 is a clinical study titled "Central Executive Training and Parent Training for ADHD". The goal of the current project is to combine two evidence- based treatments for school-aged children with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized training intervention that improves ADHD symptoms and academic functioning by improving childr...

What is the current status of trial NCT05492422?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-10-03. Estimated completion is 2027-07-31.

What conditions does trial NCT05492422 study?

This clinical trial studies the following conditions: ADHD.

What interventions are being tested in trial NCT05492422?

The interventions under investigation include: Central Executive Training (CET) (DEVICE), Behavioral Parent Training (BPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05492422?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05492422 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.